Project Grant R21DA062872
Award Date
6/1/25
Completion Date
5/31/27
Dollars Obligated
$490K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This federal Project Grant award, worth $445,000 and running from September 1, 2024 to August 31, 2027, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award aims to develop and pilot test a telehealth and mobile health (mHealth) intervention called MOMENT-V to address cannabis use disorder (CUD) in young adults aged 18-26 years. The intervention combines telehealth-delivered motivational enhancement therapy...
The National Institute on Drug Abuse (NIDA) awarded a $645,594 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Ricovr Healthcare Inc., a minority-owned small business located in Princeton, New Jersey. This Phase I grant will fund the feasibility demonstration of a novel point-of-need (PON) platform device called XALIVA for the accurate and destigmatized detection of recent cannabis use. The key products or services to be delivered include: Proving the...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $668,110 to Washington State University to refine and assess the feasibility and acceptability of a technology-based intervention for college students. The intervention aims to increase young adults' knowledge of cannabis products, laws, and associated risks, in order to reduce cannabis misuse among college students. The study will involve focus...
This National Institute on Drug Abuse (NIDA) Project Grant award of $280,207 under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to develop a novel mobile cannabis intervention tool called the Adolescent CLEAR30 (A-CLEAR30) for youth aged 13-17 who are regular cannabis users. The proposed intervention will leverage the existing CLEAR30 mobile program as a foundation, offering tailored tools such as personalized feedback, daily communications, guided meditations, resources,...
This Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) provides $2,286,303.00 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct a 10-week, multi-method, randomized study on the temporal relationship between cannabis use and mood and suicidal ideation among 200 school-based adolescents aged 12-18 with daily or near daily cannabis use, current depression, and past month suicidal...
The U.S. National Institute on Drug Abuse (NIDA) awarded a $587,936 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Vox Biomedical LLC, a for-profit limited liability company in Bedford, Massachusetts. The goal of this 2-year project (8/15/2024 - 7/31/2025) is to develop a method for capturing and concentrating exhaled breath aerosols containing trace amounts of tetrahydrocannabinol (THC) and other substances using electrostatic charging and deposition onto...
This $177,110 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research into the impact of cannabis legalization and commercialization on substance use and mental health outcomes among individuals with psychosis. The awardee, the Cambridge Public Health Commission (doing business as the Cambridge Health Alliance), will utilize quasi-experimental difference-in-difference methods to analyze...
This $1,980,270 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a study to assess the neurobehavioral impacts of medical cannabis use in adults aged 35-65 who have chronic pain. The overarching aim is to evaluate cognition, neural function, and substance use disorder risk in a sample of 120 medical cannabis patients compared to 60 non-cannabis using controls. The study will measure behavioral...
This $376,078 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support an experimental study to explore the antecedents and consequences of cannabis use for coping purposes. The 5-year study will examine whether cannabis use increases after stress induction among individuals who use cannabis to cope, as well as the potential moderating roles of social anxiety and inhibitory control. It will also...
This $311,000 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development and pilot testing of a novel mobile health (mHealth) intervention to reduce frequent and high-intensity cannabis use among young adults not attending college. The proposed "TAKE 5" intervention integrates online personalized feedback and tailored text messages to address five key domains related to cannabis use...